Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust · 20 lines · as of Mar 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Amplify Weight Loss Drug & Treatment ETF |
|---|---|
| Novo Nordisk A/S | 11.89 % |
| Eli Lilly & Co | 11.56 % |
| Regeneron Pharmaceuticals, Inc. | 6.77 % |
| Amgen Inc | 6.27 % |
| Chugai Pharmaceutical Co Ltd | 6.00 % |
| CSPC Pharmaceutical Group Ltd | 5.03 % |
| Arrowhead Pharmaceuticals Inc | 4.96 % |
| AbbVie Inc | 4.75 % |
| AstraZeneca PLC | 4.66 % |
| Pfizer Inc | 4.62 % |
| Merck & Co Inc | 4.48 % |
| Shionogi & Co Ltd | 4.46 % |
| Roche Holding AG | 4.46 % |
| Innovent Biologics Inc | 4.43 % |
| Scholar Rock Holding Corp | 2.37 % |
| Viking Therapeutics Inc | 2.21 % |
| Structure Therapeutics Inc | 2.02 % |
| Zealand Pharma A/S | 1.74 % |
| Hanmi Pharm Co Ltd | 1.28 % |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 1.23 % |
1 funds, 20 lines read.